Literature DB >> 12194553

Experience with Lap-band System up to 7 years.

Marc Vertruyen1.   

Abstract

BACKGROUND: Morbid obesity occurs in 2-5% of the population of Western countries. Laparoscopic adjustable silicone gastric banding was designed to be a minimally invasive, adjustable and reversible procedure for the treatment of morbid obesity.
MATERIAL AND METHODS: The Lap-band System was evaluated retrospectively in a series of 543 patients. Data on preoperative aspects and postoperative outcome and weight loss patterns at up to 7 years follow-up (median follow-up 36 months) are presented.
RESULTS: The most important late complication was total and irreversible food intolerance due to proximal pouch dilatation, which occurred in 24 patients (4.6%). 20 of these patients (3.8%) had had a proximal pouch calibration with 25 cc; 4 patients were calibrated with 15 cc. The mean BMI had fallen from 44 kg/m2 to 33.2 kg/m2 and was stable after a follow-up of up to 86 months (median 36 months).
CONCLUSION: The Lap-band System is an effective procedure for achieving appreciable and stable weight loss at up to 7 years of follow-up (median 36 months). The minimally invasive approach was associated with a short hospital stay and a low rate of complications. Preoperative patient selection, detailed information and availability of the multidisciplinary team permitted us to achieve good longstanding results.

Entities:  

Mesh:

Year:  2002        PMID: 12194553     DOI: 10.1381/096089202762252361

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up.

Authors:  Camilo Boza; Cristian Gamboa; Gustavo Perez; Fernando Crovari; Alex Escalona; Fernando Pimentel; Alejandro Raddatz; Sergio Guzman; Luis Ibáñez
Journal:  Surg Endosc       Date:  2010-07-22       Impact factor: 4.584

2.  Band slippage and erosion after laparoscopic gastric banding: a meta-analysis.

Authors:  Rishi Singhal; Catherine Bryant; Mark Kitchen; Khalid S Khan; Jon Deeks; Boliang Guo; Paul Super
Journal:  Surg Endosc       Date:  2010-07-31       Impact factor: 4.584

3.  [Gastric banding: surgical and technical aspects].

Authors:  R A Weiner
Journal:  Chirurg       Date:  2005-07       Impact factor: 0.955

Review 4.  Surgery for morbid obesity.

Authors:  John M H Bennett; Samir Mehta; Michael Rhodes
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

5.  A serious but rare complication of laparoscopic adjustable gastric banding: bowel obstruction due to caecal volvulus.

Authors:  Afshin Agahi; Robin Harle
Journal:  Obes Surg       Date:  2009-05-13       Impact factor: 4.129

6.  The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study.

Authors:  Katie Weichman; Christine Ren; Marina Kurian; Allison Youn Heekoung; Roman Casciano; Lee Stern; George Fielding
Journal:  Surg Endosc       Date:  2010-06-24       Impact factor: 4.584

Review 7.  Biliopancreatic diversion in the surgical treatment of morbid obesity.

Authors:  Robrecht H G G Van Hee
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

Review 8.  Long-term outcomes of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese patients with and without co-morbidities.

Authors:  Luigi Angrisani; Pier Paolo Cutolo; Giampaolo Formisano; Gabriella Nosso; Antonella Santonicola; Giuliana Vitolo
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

9.  Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial.

Authors:  Mario Morino; Mauro Toppino; Gisella Bonnet; Gianmattia del Genio
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

10.  Reoperations after gastric banding: replacement or alternative procedures?

Authors:  Marco Bueter; Andreas Thalheimer; Alexander Wierlemann; Martin Fein
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.